Oxidative stress in malignant melanoma and non-melanoma skin cancer

British Journal of Dermatology

Volumn 148, Issue 5, 2003, Pages 913-922

  Sander, C S ^a   Hamm, F ^a   Elsner, P ^a   Thiele, Jens J ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Antioxidant enzymes; Catalase; Lipid peroxidation; Malignant melanoma; Malondialdehyde; Superoxide dismutase

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIPID PEROXIDATION; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIATION EXPOSURE; REDUCTION; SKIN BIOPSY; SKIN CANCER; SOLAR RADIATION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; ULTRAVIOLET RADIATION;

ADOLESCENT; AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CATALASE; FEMALE; HUMANS; KERATOSIS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MELANOMA; MIDDLE AGED; NEVUS; OXIDATIVE STRESS; SKIN NEOPLASMS; SUPEROXIDE DISMUTASE; ULTRAVIOLET RAYS;

EID: 0037525665     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05303.x     Document Type: Article

References (52)

1. Black HS, deGruijl FR, Forbes PD et al. Photocarcinogenesis: an overview. J Photochem Photobiol B 1997; 40: 29-47.
2. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 2001; 45: 528-36.
3. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994; 20: 219-40.
4. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001; 63: 8-18.
5. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774-8.
6. Gloster HM Jr, Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996; 22: 217-26.
7. Urbach F. Ultraviolet radiation and skin cancer of humans. J Photochem Photobiol B 1997; 40: 3-7.
8. Corona R, Dogliotti E, D'Errico M et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 2001; 137: 1162-8.
9. Hofmann UB, Van Westphal JR, Muijen GNP, Ruiter DJ. Matrix metalloproteinases in human melanoma. J Invest Dermatol 2000; 115: 337-44.
10. Peak MJ, Peak JG. Solar ultraviolet effects on mammalian cell DNA. In: Oxidative Stress in Dermatology (Fuchs J, Packer L, eds). New York: Marcel Dekker, 1993; 169-86.
11. de Gruijl FR. Photocarcinogenesis: UVA vs UVB. Methods Enzymol 2000; 319: 359-66.
12. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 361-70.
13. Sasaki H, Akamatsu H, Horio T. Effects of a single exposure to UVB radiation on the activities and protein levels of copper-zinc and manganese superoxide dismutase in cultured human keratinocytes. Photochem Photobiol 1997; 65: 707-13.
14. Leccia MT, Richard MJ, Joanny-Crisci F et al. UV-A1 cytotoxicity and antioxidant defence in keratinocytes and fibroblasts. Eur J Dermatol 1998; 8: 478-82.
15. Poswig A, Wenk J, Brenneisen P et al. Adaptive antioxidant response of manganese-superoxide dismutase following repetitive UVA irradiation. J Invest Dermatol 1999; 112: 13-18.
16. Leccia MT, Yaar M, Allen N, Beani JC. Solar simulated irradiation modulates gene expression and activity of antioxidant enzymes in cultured human dermal fibroblasts. Exp Dermatol 2001; 10: 272-9.
17. Shindo Y, Witt E, Packer L. Antioxidant defense mechanisms in murine epidermis and dermis and their responses to ultraviolet light. J Invest Dermatol 1993; 100: 260-5.
18. Okada K, Takahashi Y, Ohnishi K et al. Time-dependent effect of chronic UV irradiation on superoxide dismutase and catalase activity in hairless mice skin. J Dermatol Sci 1994; 8: 183-6.
19. Sander CS, Chang H, Salzmann S et al. Photoaging is associated with protein oxidation in human skin in vivo. J Invest Dermatol 2002; 118: 618-25.
20. Rhie G, Shin MH, Seo JY et al. Aging- and photoaging-dependent changes of enzymic and nonenzymic antioxidants in the epidermis and dermis of human skin in vivo. J Invest Dermatol 2001; 117: 1212-17.
21. Darr D, Fridovich I. Free radicals in cutaneous biology. J Invest Dermatol 1994; 102: 671-5.
22. Thiele JJ, Dreher F, Packer L. Antioxidant defense systems in skin. In: Cosmeceuticals, Drugs Vs Cosmetics (Elsner P, Maibach H, eds). New York: Marcel Dekker. 2000: 145-87.
23. Marnett LJ. Chemistry and biology of DNA, damage by malondialdehyde. IARC Sci Publ 1999; 150: 17-27.
24. Hartley DP, Kolaja KL, Reichard J, Petersen DR. 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection and lobular localization. Toxicol Appl Pharmacol 1999; 161: 23-33.
25. Moore K, Roberts LJ 2nd. Measurement of lipid peroxidation. Free Radic Res 1998; 28: 659-71.
26. Picardo M, Grammatico P, Roccella F et al. Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. J Invest Dermatol 1996; 107: 322-6.
27. Meyskens FL Jr, Chau HV, Tohidian N, Buckmeier J. Luminol-enhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress. Pigment Cell Res 1997; 10: 184-9.
28. Rabilloud T, Asselineau D, Miquel C et al. Deficiency in catalase activity correlates with the appearance of tumor phenotype in human keratinocytes. Int J Cancer 1990; 45: 952-6.
29. Lehtola K, Laurikainen L, Leino L et al. Antioxidant enzymes are elevated in dimethylbenz (a) anthracene-induced neoplastic murine keratinocytes containing an active ras-Ha oncogene. J Cancer Res Clin Oncol 1995; 121: 402-6.
30. Applegate LA, Scaletta C, Labidi F et al. Susceptibility of human melanoma cells to oxidative stress including UVA radiation. Int J Cancer 1996; 67: 430-4.
31. Bittinger F, Gonzalez-Garcia JL, Klein CL et al. Production of superoxide by human malignant melanoma cells. Melanoma Res 1998; 8: 381-7.
32. Meyskens FL Jr, McNulty SE, Buckmeier JA et al. Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes. Free Radic Biol Med 2001; 31: 799-808.
33. Offner FA, Wirtz HC, Schiefer J et al. Interaction of human malignant melanoma (ST-ML-12) tumor spheroids with endothelial cell monolayers. Damage to endothelium by oxygen-derived free radicals. Am J Pathol 1992; 141: 601-10.
34. Grammatico P, Maresca V, Roccella F et al. Increased sensitivity to peroxidizing agents is correlated with an imbalance of antioxidants in normal melanocytes from melanoma patients. Exp Dermatol 1998; 7: 205-12.
35. Picardo M, Maresca V, Eibenschutz L et al. Correlation between antioxidants and phototypes in melanocytes cultures. A possible link of physiologic and pathologic relevance. J Invest Dermatol 1999; 113: 424-5.
36. Schadendorf D, Zuberbier T, Diehl S et al. Serum manganese superoxide dismutase is a new tumour marker for malignant melanoma. Melanoma Res 1995; 5: 351-3.
37. Meyskens FL Jr, Buckmeier JA, McNulty SE et al. Activation of nuclear factor-kappa B in human metastatic melanoma cells and the effect of oxidative stress. Clin Cancer Res 1999; 5: 1197-202.
38. Meyskens FL Jr, Farmer P, Fruehauf JP. Redox regulation in human melanocytes and melanoma. Pigment Cell Res 2001; 14: 148-54.
39. Brar SS, Kennedy TP, Whorton AR et al. Reactive oxygen species from NAD (P) H. quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells. Am J Physiol Cell Physiol 2001; 280: C659-76.
40. Bravard A, Cherbonnel-Lasserre C, Reillaudou M et al. Modifications of the antioxidant enzymes in relation to chromosome imbalances in human melanoma cell lines. Melanoma Res 1998; 8: 329-35.
41. Hirose K, Longo DL, Oppenheim JJ, Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J 1993; 7: 361-8.
42. Girotti AW. Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms. J Photochem Photobiol B 2001; 63: 103-13.
43. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998; 39: 1529-42.
44. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
45. Guertin F, Brunet S, Gavino V et al. Malondialdehyde-modified high-density lipoprotein cholesterol: plasma removal, tissue distribution and biliary sterol secretion in rats. Biochim Biophys Acta 1994; 1214: 137-42.
46. Zarkovic N, Tillian MH, Schaur J et al. Inhibition of melanoma B16-F10 growth by lipid peroxidation product 4-hydroxynonenal. Cancer Biother 1995; 10: 153-6.
47. Vural P, Canbaz M, Selcuki D. Plasma antioxidant defense in actinic keratosis and basal cell carcinoma. J Eur Acad Dermatol Venereol 1999; 13: 96-101.
48. Kobayashi T, Matsumoto M, Iizuka H et al. Superoxide dismutase in psoriasis, squamous cell carcinoma and basal cell epithelioma: an immunohistochemical study. Br J Dermatol 1991; 124: 555-9.
49. Borrello S, Seccia A, Galeotti T et al. Protective enzymes in human epidermal carcinomas and psoriasis. Arch Dermatol Res 1984; 276: 338-40.
50. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med 1996; 74: 297-312.
51. de Gruijl FR, Kranen HJ, Mullenders LH. UV-induced DNA: damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B 2001; 63: 19-27.
52. Staibano S, Lo Muzio L, Pannone G et al. P53 and hMSH2 expression in basal cell carcinomas and malignant melanomas from photoexposed areas of head and neck region. Int J Oncol 2001; 19: 551-9.